Hyperfine, Inc. (HYPR) vs Outset Medical, Inc. (OM)
A side-by-side comparison of Hyperfine, Inc. and Outset Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HYPR
Hyperfine, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
OM
Outset Medical, Inc.
$4.09HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT
Total return — HYPR vs OM
growth of $100 · dividends reinvested · last 6yHYPR -91.2% (-33.3%/yr)OM -99.5% (-58.1%/yr)HYPR compounded faster over this window
Log scale — wide-divergence pair
HYPR OM
HYPR vs OM: by the numbers
- •HYPR is the larger company ($76M vs $76M market cap).
- •Both run net losses; OM's is the smaller (-63.06% vs -210.75% net margin).
- •HYPR grew revenue faster over the past five years (77.73% vs 8.28% CAGR).
Metrics side by side
Valuation
| Metric | HYPR | OM |
|---|---|---|
| P/S ratio | 4.61 | 0.64 |
| P/B ratio | 2.07 | 0.79 |
Profitability
| Metric | HYPR | OM |
|---|---|---|
| Gross margin | 51.41% | 41.76% |
| Operating margin | -273.43% | -56.06% |
| Net margin | -210.75% | -63.06% |
| ROE | -94.81% | -77.12% |
| ROIC | -62.98% | -33.27% |
Growth (annualized)
| Metric | HYPR | OM |
|---|---|---|
| Revenue CAGR (5Y) | 77.73% | 8.28% |
| Total return CAGR (5Y) | -38.34% | -64.47% |
Frequently asked
- Which has grown faster, HYPR or OM?
- Over the past five years, HYPR grew revenue faster — HYPR at a 77.73% CAGR versus OM at 8.28%.
- How have HYPR and OM total returns compared?
- Over the past 5 years, HYPR delivered -38.34% and OM delivered -64.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Hyperfine ROEOutset Medical ROEHyperfine operating marginOutset Medical operating marginHyperfine revenue growthOutset Medical revenue growthHyperfine free cash flowOutset Medical free cash flow
Hyperfine & Outset Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.